Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Leishen Energy Holding Co., Ltd. - Ordinary Shares
(NQ:
LSE
)
5.330
-0.065 (-1.20%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Aug 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Leishen Energy Holding Co., Ltd. - Ordinary Shares
< Previous
1
2
3
4
Next >
Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts
March 07, 2025
Encouraging Progression Free Survival (PFS) data observed in patients with salivary gland cancers compared to conventional treatments
From
AVACTA GROUP PLC
Via
GlobeNewswire
HUTCHMED Announces that it has Completed Enrollment of a Phase II Registration Study of Fanregratinib (HMPL-453) for Intrahepatic Cholangiocarcinoma in China
March 06, 2025
From
HUTCHMED (China) Limited
Via
GlobeNewswire
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
March 05, 2025
From
HUTCHMED (China) Limited
Via
GlobeNewswire
HUTCHMED to Announce 2024 Final Results
February 19, 2025
From
HUTCHMED (China) Limited
Via
GlobeNewswire
Caledonia Mining Corporation Plc: Appointment of New Chief Financial Officer
February 19, 2025
From
Caledonia Mining Corporation Plc
Via
GlobeNewswire
Leishen Energy Holding Co., Ltd. Announces Fiscal Year 2024 Financial Results Highlighting Strong Operating Cash Flow and Stable Gross Margins
February 18, 2025
From
Leishen Energy Holding Co., Ltd.
Via
GlobeNewswire
Caledonia Mining Corporation Plc: Appointments of Stefan Buys and Lesley Goldwasser as Non-Executive Directors
February 14, 2025
From
Caledonia Mining Corporation Plc
Via
GlobeNewswire
Metals & Mining Virtual Investor Conference Agenda Announced for February 12th and 13th
February 10, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
January 30, 2025
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Nexxen Fuels Growth with Live Sports Offerings and Key Partnerships, Reaching Highly Engaged Audiences Across Channels
January 28, 2025
By collaborating with publisher partners and DSPs, Nexxen saw an increase in spend on live sports packages, including a 315% increase from StackAdapt campaigns
From
Nexxen International Ltd.
Via
GlobeNewswire
Caledonia Mining Corporation Plc: Blanket Mine Q4 and FY 2024 Production and 2025 Guidance
January 14, 2025
Blanket production meets guidance; continued investment in growth and efficiency
From
Caledonia Mining Corporation Plc
Via
GlobeNewswire
HUTCHMED Announces NMPA Full Approval for ORPATHYS® (savolitinib) in China for Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC
January 13, 2025
From
HUTCHMED (China) Limited
Via
GlobeNewswire
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements
January 07, 2025
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Nexxen Launches Nexxen U, a First-of-its-Kind Education Program for Linear, Connected TV and Digital Convergence
January 06, 2025
From
Nexxen International Ltd.
Via
GlobeNewswire
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for ORPATHYS® and TAGRISSO® Combination in Lung Cancer Patients with MET amplification After Progression on First-Line EGFR Inhibitor Therapy
January 01, 2025
From
HUTCHMED (China) Limited
Via
GlobeNewswire
HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture
January 01, 2025
From
HUTCHMED (China) Limited
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.